Canadian Weight Loss Drugs Set to Drop in Price
Health Canada has approved Svemia, the first generic version of Wegovy, offering a cheaper path to the popular weight loss drug.
Sleep Apnea: Health Canada Approves Zepbound as First-of-Its-Kind Treatment
Health Canada has approved Zepbound® as the first medication to treat sleep apnea in adults with obesity, reducing breathing pauses by up to 50%.
Save on Ozempic: Generic Swaps Arrive in Canada
Generic Ozempic has arrived in Canada, slashing costs by two-thirds. Learn how this historic price drop benefits your health and wallet.
Should You Take Berberine? What Health Canada and the Research Say
Berberine is trending as "nature's Ozempic", but what does Health Canada actually approve it for, and is it safe to take with your medications?
No More Needles: Canada Approves a Nasal Spray to Treat Severe Allergic Reactions
Health Canada approves neffy®, a needle-free epinephrine nasal spray for anaphylaxis. Learn how it works and when it’s coming to Canada.
Health Canada Warns: Think Twice Before Injecting Peptides Bought Online
Health Canada warns against unapproved peptide injections trending online for weight loss and anti-aging, citing serious health risks and lack of regulation.
GLP-1s and Bone Health: Potential Risks for Non-Diabetics
New studies reveal a 22% higher osteoporosis risk for non-diabetics on GLP-1s. Learn how these weight-loss drugs may impact your skeletal strength.
Kidney Breakthrough: Health Canada Authorizes First-of-its-Kind Treatment for Lupus Nephritis
Health Canada authorizes Gazyva for lupus nephritis. Discover how this twice-yearly treatment improves kidney response and prevents failure.
New Study Warns of Rapid Weight Regain When Quitting Weight Loss Drugs
New research shows stopping weight loss medication leads to rapid regain, with many returning to their original weight in less than two years.
Does HRT Increase Dementia Risk? New 1M Woman Study
A study of 1M women finds HRT doesn't increase dementia risk. We dive into the findings and why women are still more likely to face Alzheimer's.
Health Canada Authorizes First 8-Week Treatment for Acute Hepatitis C
Health Canada’s approval of MAVIRET for acute HCV allows doctors to treat adults and children immediately, a key step toward the 2030 elimination goal.
Health Canada Authorizes TNKase for Treatment of Adult Stroke
Health Canada officially authorizes TNKase for treating acute ischemic stroke in adults. This pivotal approval introduces a faster, 5-second injection to emergency rooms nationwide.